Advertisement
Advertisement

NUVB

NUVB logo

Nuvation Bio Inc.

6.26
USD
Sponsored
+0.46
+7.93%
Jul 20, 16:00 UTC -4
Closed
exchange

Pre-Market

6.31

+0.05
+0.78%

Nuvation Bio Inc. Profile

About

Nuvation Bio Inc. is a biopharmaceutical company. It engages in developing differentiated and novel therapeutic candidates for unmet needs in oncology. Nuvation Bio Inc., formerly known as Panacea Acquisition Corp., is based in NEW YORK.

Info & Links

CEO

David Hung

Headquarters

1500 BROADWAY, SUITE 1401
NEW YORK, NY 10036, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.nuvationbio.com

Auditor

KPMG LLP

Share holders

36

Employees

298

Nuvation Bio Inc. Statistics

Valuation Measures

Market Capitalization2

2.20B

Enterprise Value

2.12B

Enterprise Value/EBITDA(ttm)

-14.43

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

25.59

Price to Book(mrq)

5.25

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

62.56%

Operating Margin(ttm)

-325.31%

Profit Margin(ttm)

-864.94%

Return on Equity(ttm)

-57.48%

Return on Invested Capital(ttm)

-52.07%

Return on Assets(ttm)

-35.04%

Income Statement

Revenue(ttm)

143.05M

Revenue Per Share(ttm)

0.41

Gross Profit(ttm)

129.85M

EBITDA(ttm)3

-147.23M

Net Income Available to Common(ttm)

-145.99M

Diluted EPS(ttm)

-0.60

Share Statistics

Beta (5Y Monthly)

1.60

52-Week Change

172.17%

S&P 500 52-Week Change

18.04%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

348.20M

Dividend Yield

0.00%

Float4

243.56M

% Held by Insiders

29.93%

% Held by Institutions

61.67%

Balance Sheet

Total Cash(mrq)

533.73M

Total Cash Per Share(mrq)

1.53

Total Debt(mrq)

53.12M

Total Debt/Equity(mrq)

17.31%

Current Ratio(mrq)

6.95%

Quick Ratio(mrq)

6.81%

Book Value Per Share(mrq)

0.88

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.51

Free Cash Flow(ytd)

-173.78M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement